InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: turks post# 12344

Wednesday, 10/04/2017 10:22:38 AM

Wednesday, October 04, 2017 10:22:38 AM

Post# of 16886
Yep. Agree with Serenity that Alkermes can't afford for another company to come to market with what is essentially a Vivitrol implant.

Also interesting that this happened this Summer...and shortly thereafter Titan announced a feasibility study for a kappa opioid agonist like CR845. Since CR845 has issues with being orally bioavailable, it would make sense for Cara to investigate an implant. They have a lot of money invested in this drug.

https://www.forbes.com/sites/kenkam/2017/07/06/cara-therapeutics-new-pain-drug-still-has-value-after-failed-clinical-trial/#505ff3631272
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News